Evidence map›Paper›PMID 26310307›Full record

ArticleThe Journal of infectious diseases2016

Association Between Local Pediatric Vaccination Rates and Patterns of Pneumococcal Disease in Adults.

Sundia Cassandra Pingali, Joshua L Warren, Aimee M Mead, Nancy Sharova, Susan Petit, Daniel M Weinberger

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of infectious diseases, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Review
  3. Adult Otogenic Meningitis in the Pneumococcal Conjugated Vaccines Era.International archives of otorhinolaryngology · 2020
    Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Sundia Cassandra PingaliDepartment of Epidemiology of Microbial Diseases, Yale School of Public Health.
Joshua L WarrenDepartment of Biostatistics, Yale School of Public Health.
Aimee M MeadDepartment of Epidemiology of Microbial Diseases, Yale School of Public Health.
Nancy SharovaConnecticut Department of Public Health, New Haven, Connecticut.
Susan PetitConnecticut Department of Public Health, New Haven, Connecticut.
Daniel M WeinbergerDepartment of Epidemiology of Microbial Diseases, Yale School of Public Health.
Yale University · USConnecticut Department of Public Health · US

Funding

Yale Study Support Suite (YES3): Dashboard and Web Portal Software Supporting Research Workflow through integrated, customizable REDCap External ModulesP30AG021342 · NIA · YALE UNIVERSITY · PI Denise Esserman · 2002 to 2026
$37.9M
Yale University Clinical and Translational Science Award ProgramUL1TR000142 · NCATS · YALE UNIVERSITY · PI SHERWIN, ROBERT S · 2012 to 2015
$31.8M
Forecasting pneumococcal serotype frequencies to develop adult-specific vaccinesR56AI110449 · NIAID · YALE UNIVERSITY · PI WEINBERGER, DANIEL MARTIN · 2015 to 2015
$427k
NCATS NIH HHS UL1 TR000142NIAID NIH HHS R56 AI110449NIAID NIH HHS R56AI110449-01A1NIA NIH HHS P30 AG021342NIA NIH HHS P30AG021342
6 · The paper itself

Abstract

backgroundPneumococcal conjugate vaccine (PCV) is now recommended for use in adults in the United States. Because vaccination of children with PCVs protects adults from the targeted serotypes, local variations in PCV uptake among children could influence disease patterns in adults.

methodsWe obtained ZIP code-level data on invasive pneumococcal disease (IPD) from an active population-based surveillance system in Connecticut (study interval, 1998-2009) and ZIP code-level data on immunization with at least 3 or at least 4 doses of 7-valent PCV (PCV7) from the state immunization registry. We fit logistic regression models to estimate the proportion of IPD cases among adults aged >40 years that were caused by PCV7-targeted serotypes. Covariates included ZIP code-level socioeconomic indicators (eg, percentage of the population that was black and income per capita), the percentage of the population that received 3 or 4 doses of PCV7 (mean centered), and a linear spline to control for the average rate of decline across all ZIP codes.

resultsZIP codes that had a higher proportion of children that did not complete the 4-dose PCV7 series had a higher proportion of adult IPD cases caused by PCV7 serotypes.

conclusionsLocal variations in PCV uptake (and receipt of the booster dose) might influence the effectiveness of PCVs in preventing pneumococcal disease in adults.

Indexed as

AdolescentAdultAgedAged, 80 and overChildChild, PreschoolConnecticutHeptavalent Pneumococcal Conjugate VaccineHumansInfantMiddle AgedPneumococcal InfectionsSerotypingStreptococcus pneumoniaeVaccinationYoung AdultHeptavalent Pneumococcal Conjugate Vaccineconjugate vaccineherd immunityindirect effectspneumococcal

Identifiers

PMID26310307
PMCPMC4721904
OpenAlexW2167128497

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.